The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan

Peer Review reports

Original Submission
12 Jan 2020	Submitted	Original manuscript
4 Mar 2020	Reviewed	Reviewer Report - Christian Roever
9 Jun 2020	Author responded	Author comments - Mark Jones
Resubmission - Version 2
9 Jun 2020	Submitted	Manuscript version 2
Publishing
12 Jul 2020	Editorially accepted
26 Aug 2020	Article published	10.1186/s13063-020-04602-w

Back to article page